1-3 of 3
Nita Seibel
Close
Sort by
Journal Articles

Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group

Clinical Trials & Observations
Beverly J. Lange, Franklin O. Smith, James Feusner, Dorothy R. Barnard, Patricia Dinndorf, Stephen Feig, Nyla A. Heerema, Carola Arndt, Robert J. Arceci, Nita Seibel, Margie Weiman, Kathryn Dusenbery, Kevin Shannon, Sandra Luna-Fineman, Robert B. Gerbing, Todd A. Alonzo
Journal: Blood
Blood (2008) 111 (3): 1044–1053.
https://doi.org/10.1182/blood-2007-04-084293
Published: 2008
Includes: Supplemental data
Journal Articles

Improved Outcome of Children with Down Syndrome (DS) and High Risk Acute Lymphocytic Leukemia (HR-ALL): A Report of CCG-1961.

Caroline Hastings, James A. Whitlock, Mei La, Nita Seibel
Journal: Blood
Blood (2007) 110 (11): 586.
https://doi.org/10.1182/blood.V110.11.586.586
Published: 2007
Journal Articles

Retrospective Survey of Children Treated for Relapsed Acute Lymphoblastic Leukemia (Complete Remission (CR) Rates): A Report from the Therapeutic Advances in Childhood Leukemia (TACL) Consortium.

Richard H. Ko, MD, Lingyun Ji, MS, Richard Sposto, PhD, Phillip Barnette, MD, Bruce Bostrom, MD, Raymond Hutchinson, MD, Elizabeth Raetz, MD, Nita Seibel, MD, Clare Twist, MD, Elena Eckroth, BA, Paul Gaynon, MD, Mignon Loh, MD
Journal: Blood
Blood (2007) 110 (11): 854.
https://doi.org/10.1182/blood.V110.11.854.854
Published: 2007